GENinCode is a leading brand that offers genetic testing for personalized healthcare and medicine. With a focus on cardiovascular disease prevention, diagnosis, and treatment, GENinCode harnesses the power of both monogenic and polygenic risk assessment to combat one of the world's most prevalent health problems. Their test products have been developed to help physicians make improved clinical decisions by delivering comprehensive risk assessments.

By stratifying patients and identifying the most appropriate treatment pathways aligned with clinical guidelines, GENinCode ensures optimal outcomes. Their technology combines clinical algorithms and artificial intelligence to provide advanced patient risk assessment and enable disease prediction and prevention. With over 15 years of research and development in cardiovascular genomics, in collaboration with leading institutions and clinical experts, GENinCode has amassed deep knowledge and understanding of the interactions between a patient's genomic profile, lifestyle, and clinical risk factors